We propose a new approach to the synthesis of 17-pyrazolylandrostanes on the basis of 17β-[3-(dimethylamino)acryloyl]-16α,17α-epoxy-3β-hydroxyandrost-5-ene. This epoxyandrostene was shown to react with hydrazine hydrate, producing 17α-hydrazinyl-3β,16α-dihydroxy-17β-(1H-pyrazolyl-3-yl)androst-5-ene that was used in reactions with aromatic aldehydes, leading to 17-hydrazones. The treatment of 17β-[3-(dimethylamino)acryloyl]-16α,17α-epoxy-3β-hydroxyandrost-5-ene with phenylhydrazine led to the formation of 3β,16α-dihydroxy-17-(1-phenyl-1H-pyrazol-5-yl)androst-5-ene. At the same time, the reactions of epoxyandrostene with methylhydrazine or benzylamine proceeded with conservation of the epoxide ring and led to the formation of 16α,17-epoxyandrostanes containing a 1-methyl-1H-pyrazol-5-yl or 3-(benzylamino)acryloyl substituent at position 17, respectively. The obtained hydrazones exhibited a moderate antiproliferative activity against the MCF-7 breast cancer cell line. The strongest antiproliferative potential was identified in the case of 17α-[(4-bromobenzylidene)hydrazinyl]-3β,16α-dihydroxy-17β-(1H-pyrazol-3-yl)androst-5-ene with an IC50 value around 16 μM.
Similar content being viewed by others
References
Mounnissamy, V. M.; Joseva, S. World J. Pharm. Res. 2021, 10, 167.
Ansari, A.; Ali, A.; Asif, M.; Shamsuzzaman New J. Chem. 2017, 41, 16.
Nehra, B.; Rulhania, S.; Jaswal, S.; Kumar, B.; Singh, G.; Monga, V. Eur. J. Med. Chem. 2020, 205, 112666.
Stulov, S. V.; Misharin, A. Y. Chem. Heterocycl. Compd. 2013, 48, 1431.
Zavarzin, I. V.; Chertkova, V. V.; Levina, I. S.; Chernoburova, E. I. Russ. Chem. Rev. 2011, 80, 661.
Ibrahim-Ouali, M.; Dumur, F. ARKIVOC 2019, (i), 304.
Ke, S. Mini-Rev. Med. Chem. 2018, 18, 745.
Iqbal, A.; Siddiqui, T. Steroids 2021, 170, 108827.
Bansal, R.; Singh, R. Future Med. Chem. 2020, 12, 949.
Mohareb, R. M.; Elmegeed, G. A.; Abdel-Salam, O. M. E.; Doss, S. H.; William, M. G. Steroids 2011, 76, 1190.
Mohareb, R.; Hana, H. Acta Pharm. 2008, 58, 29.
Cai, X.; Zhao, S.; Cai, D.; Zheng, J.; Zhu, Z.; Wei, D.; Zheng, Z.; Zhu, H.; Chen, Y. Steroids 2019, 146, 70.
Fan, N.-J.; Tang, J.-J.; Li, H.; Li, X.-J.; Luo, B.; Gao, J.-M. Eur. J. Med. Chem. 2013, 69, 182.
Banday, A. H.; Mir, B. P.; Lone, I. H.; Suri, K. A.; Kumar, H. M. S. Steroids 2010, 75, 805.
Li, J.; Zhao, X.; Li, L.; Yuan, Z.; Tan, F.; Shi, B.; Zhang, J. Steroids 2016, 107, 45.
Li, J.; Huo, H.; Guo, R.; Liu, B.; Li, L.; Dan, W.; Xiao, X.; Zhang, J.; Shi, B. Eur. J. Med. Chem. 2017, 130, 1.
Huo, H.; Jiang, W.; Sun, F.; Li, J.; Shi, B. Steroids 2021, 176, 108931.
Kulmány, Á. E.; Frank, É.; Kovács, D.; Kirisits, K.; Krupitza, G.; Neuperger, P.; Alföldi, R.; Puskás, L. G.; Szebeni, G. J.; Zupkó, I. Biomed. Pharmacother. 2021, 140, 111728.
Tantawy, M. A.; Nafie, M. S.; Elmegeed, G. A.; Ali, I. A. I. Bioorg. Chem. 2017, 73, 128.
Cerri, A.; Bianchi, G.; Ferrari, P.; Ferrandi, M.; Barassi, P.; Zaza, A.; Rocchetti, M.; Ronchi, C.; Hsu, S.-C. EP Patent 3599243.
Ling, Y.-z.; Li, J.-s.; Liu, Y.; Kato, K.; Klus, G. T.; Brodie, A. J. Med. Chem. 1997, 40, 3297.
Njar, V. C. O.; Kato, K.; Nnane, I. P.; Grigoryev, D. N.; Long, B. J.; Brodie, A. M. H. J. Med. Chem. 1998, 41, 902.
Kovács, D.; Wölfling, J.; Szabó, N.; Szécsi, M.; Schelz, Z.; Zupkó, I.; Frank, É. Eur. J. Med. Chem. 2016, 120, 284.
Abdalla, M. M.; Al-Omar, M. A.; Bhat, M. A.; Amr, A.-G. E.; Al-Mohizea, A. M. Int. J. Biol. Macromol. 2012, 50, 1127.
Banday, A. H.; Saeed, B. A.; Al-Masoudi, N. A. Anti-Cancer Agents Med. Chem. 2021, 21, 1671
Banday, A. H.; Shameem, S. A.; Jeelani, S. Steroids 2014, 92, 13.
Pelc, B.; Hodková, J. Collect. Czech. Chem. Commun. 1969, 34, 442.
Clinton, R. O. US Patent 3317520.
Nambara, T.; Shimada, K.; Nemoto, T.; Goya, S. Chem. Pharm. Bull. 1970, 18, 1658.
Julian, P. L.; Meyer, E. W.; Karpel, W. J.; Waller, I. R. J. Am. Chem. Soc. 1950, 72, 5145.
Komkov, A. V.; Chizhov, A. O.; Shashkov, A. S.; Zavarzin, I. V. Russ. Chem. Bull. 2018, 67, 1088.
Malykh, A. G.; Pavlov, A. R.; Komkov, A. V.; Volkova, Y. A.; Menchikov, L. G.; Zavarzin, I. V. Mendeleev Commun. 2021, 31, 667.
Komkov, A. V.; Sukhanova, A. A.; Menchikov, L. G.; Zavarzin, I. V. Chem. Heterocycl. Compd. 2022, 58, 547.
Suginome, H.; Uchida, T.; Kizuka, K.; Masamune, T. Bull. Chem. Soc. Jpn. 1980, 53, 2285.
Suginome, H.; Ohue, Y.; Orito, K. J. Chem. Soc., Perkin Trans. 1 1987, 1247.
Mateos, J. L.; Chao, O.; Flores R, H. Tetrahedron 1963, 19, 1051.
Eadon, G.; Popov, S.; Djerassi, C. J. Am. Chem. Soc. 1972, 94, 1282.
Cui, J.; Liu, L.; Zhao, D.; Gan, C.; Huang, X.; Xiao, Q.; Qi, B.; Yang, L.; Huang, Y. Steroids 2015, 95, 32.
Mistry, S.; Singh, A. K. Future J. Pharm. Sci. 2022, 8, 7.
Ilovaisky, A. I.; Merkulova, V. M.; Chernoburova, E. I.; Shchetinina, M. A.; Salnikova, D. I.; Scherbakov, A. M.; Zavarzin, I. V.; Terent'ev, A. O. J. Steroid Biochem. Mol. Biol. 2021, 214, 106000.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Khimiya Geterotsiklicheskikh Soedinenii, 2023, 59(8), 554–563
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Komkov, A.V., Menchikov, L.G., Dmitrenok, A.S. et al. A new approach to the synthesis of 17-pyrazolylandrostane. Chem Heterocycl Comp 59, 554–563 (2023). https://doi.org/10.1007/s10593-023-03233-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10593-023-03233-8